GNLX stock

Genelux Corporation Common Stock (GNLX) earnings · rev $8.0K

These earnings events as JSON? API free 100/day

Genelux Corporation Common Stock (GNLX) is a biotechnology company listed on US.

This GNLX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.

Latest reported GNLX revenue for 2025-12-31 was $8.0K. Net income was -$32.1M. Revenue was up 0.0% from 2024-12-31 to 2025-12-31. GNLX currently screens at market cap $130.6M.

When the next GNLX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.

The change that matters: Revenue was up 0.0% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.

Not investment advice. Full GNLX research stays on the stock page; the tape stays on the quote page.

GNLX earnings FAQ

What are GNLX's latest revenue and net income?

Latest cached Genelux Corporation Common Stock (GNLX) revenue for Dec 31, 2025 was $8.0K. Net income was -$32.1M. Statements: https://lician.com/financials/gnlx

What is GNLX's latest diluted EPS?

Latest cached Genelux Corporation Common Stock (GNLX) diluted EPS for Dec 31, 2025 was -$0.86.

What period does the latest GNLX earnings print cover?

The latest cached Genelux Corporation Common Stock (GNLX) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.

How did GNLX revenue change from the prior cached period?

Cached Genelux Corporation Common Stock (GNLX) revenue was unchanged from $8.0K (Dec 31, 2024) to $8.0K (Dec 31, 2025). Statements: https://lician.com/financials/gnlx

Where are GNLX earnings listed?

Cached earnings facts for Genelux Corporation Common Stock (GNLX) are listed at https://lician.com/earnings/gnlx. Statements: https://lician.com/financials/gnlx

Not investment advice.

Full GNLX analysis